Searching for novel Cdk5 substrates in brain by comparative phosphoproteomics of wild type and Cdk5-/- mice

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Contreras Vallejos, Erick ^a   Utreras, Elías ^a   Bórquez, Daniel A ^a,e   Prochazkova, Michaela ^b   Terse, Anita ^b   Jaffe, Howard ^c   Toledo, Andrea ^d   Arruti, Cristina ^d   Pant, Harish C ^c   Kulkarni, Ashok B ^b   González Billault, Christian ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^e UNIVERSIDAD DIEGO PORTALES   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; G PROTEIN REGULATED INDUCER OF NEURITE OUTGROWTH 1; MARCKS PROTEIN; PHOSPHOPROTEIN; PROTEIN P35; UNCLASSIFIED DRUG; CDK5 PROTEIN, MOUSE; GPRIN1 PROTEIN, MOUSE; MEMBRANE PROTEIN; MYRISTOYLATED ALANINE-RICH C KINASE SUBSTRATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE PROTEIN; PURINE DERIVATIVE; ROSCOVITINE; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN; CHICK; EMBRYO; ENZYME SUBSTRATE; FEMALE; HIPPOCAMPUS; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEOMICS; RAT; WILD TYPE; ANIMAL; CELL LINE; CHEMISTRY; GENE DELETION; GENETICS; MASS SPECTROMETRY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANIMALS; BRAIN; CELL LINE; CYCLIN-DEPENDENT KINASE 5; GENE DELETION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MASS SPECTROMETRY; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEOMICS; PURINES; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84899088747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090363     Document Type: Article

References (74)

1. Dhavan R, Tsai LH (2001) A decade of CDK5. Nat Rev Mol Cell Biol 2: 749-759. (Pubitemid 33679837)
2. Contreras-Vallejos E, Utreras E, Gonzalez-Billault C (2012) Going out of the brain: non-nervous system physiological and pathological functions of Cdk5. Cell Signal 24: 44-52.
3. Qin H, Chan MW, Liyanarachchi S, Balch C, Potter D, et al. (2009) An integrative ChIP-chip and gene expression profiling to model SMAD regulatory modules. BMC Syst Biol 3: 73.
4. Liu CC, Hu J, Kalakrishnan M, Huang H, Zhou XJ (2009) Integrative disease classification based on cross-platform microarray data. BMC Bioinformatics 10 Suppl 1: S25.
5. Borquez DA, Olmos C, Alvarez S, Di Genova A, Maass A, et al. (2013) Bioinformatic survey for new physiological substrates of Cyclin-dependent kinase 5. Genomics 101: 221-228.
6. Utreras E, Futatsugi A, Pareek TK, Kulkarni AB (2009) Molecular Roles of Cdk5 in Pain Signaling. Drug Discov Today Ther Strateg 6: 105-111.
7. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, et al. (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci U S A 93: 11173-11178. (Pubitemid 26333137)
8. Ohshima T, Hirasawa M, Tabata H, Mutoh T, Adachi T, et al. (2007) Cdk5 is required for multipolar-to-bipolar transition during radial neuronal migration and proper dendrite development of pyramidal neurons in the cerebral cortex. Development 134: 2273-2282. (Pubitemid 47010016)
9. Arif A (2012) Extraneuronal activities and regulatory mechanisms of the atypical cyclin-dependent kinase Cdk5. Biochem Pharmacol 84: 985-993.
10. Gillardon F, Schrattenholz A, Sommer B (2005) Investigating the neuroprotective mechanism of action of a CDK5 inhibitor by phosphoproteome analysis. J Cell Biochem 95: 817-826. (Pubitemid 41420168)
11. Gillardon F, Steinlein P, Burger E, Hildebrandt T, Gerner C (2005) Phosphoproteome and transcriptome analysis of the neuronal response to a CDK5 inhibitor. Proteomics 5: 1299-1307.
12. Schnack C, Hengerer B, Gillardon F (2008) Identification of novel substrates for Cdk5 and new targets for Cdk5 inhibitors using high-density protein microarrays. Proteomics 8: 1980-1986. (Pubitemid 351775778)
13. Tseng HC, Ovaa H, Wei NJ, Ploegh H, Tsai LH (2005) Phosphoproteomic analysis with a solid-phase capture-release-tag approach. Chem Biol 12: 769-777. (Pubitemid 41009156)
14. Wu WC, Walaas SI, Nairn AC, Greengard P (1982) Calcium/phospholipid regulates phosphorylation of a Mr "87k" substrate protein in brain synaptosomes. Proc Natl Acad Sci U S A 79: 5249-5253.
15. Palmer RH, Schonwasser DC, Rahman D, Pappin DJ, Herget T, et al. (1996) PRK1 phosphorylates MARCKS at the PKC sites: serine 152, serine 156 and serine 163. FEBS Lett 378: 281-285. (Pubitemid 26023467)
16. Mosevitsky MI (2005) Nerve ending "signal" proteins GAP-43, MARCKS, and BASP1. Int Rev Cytol 245: 245-325.
17. Nakata H, Kozasa T (2005) Functional characterization of Galphao signaling through G protein-regulated inducer of neurite outgrowth 1. Mol Pharmacol 67: 695-702. (Pubitemid 40365317)
18. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
19. Dosemeci A, Jaffe H (2010) Regulation of phosphorylation at the postsynaptic density during different activity states of Ca2+/calmodulin- dependent protein kinase II. Biochem Biophys Res Commun 391: 78-84.
20. Rudrabhatla P, Grant P, Jaffe H, Strong MJ, Pant HC (2010) Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF-M/H) in Alzheimer's disease by iTRAQ. FASEB J 24: 4396-4407.
21. Graff JM, Stumpo DJ, Blackshear PJ (1989) Molecular cloning, sequence, and expression of a cDNA encoding the chicken myristoylated alanine-rich C kinase substrate (MARCKS). Mol Endocrinol 3: 1903-1906. (Pubitemid 20003677)
22. Utreras E, Maccioni R, Gonzalez-Billault C (2009) Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells. Neuroscience 161: 978-987.
23. Henriquez DR, Bodaleo FJ, Montenegro-Venegas C, Gonzalez-Billault C (2012) The light chain 1 subunit of the microtubule-associated protein 1B (MAP1B) is responsible for Tiam1 binding and Rac1 activation in neuronal cells. PLoS One 7: e53123.
24. Zolessi FR, Duran R, Engstrom U, Cervenansky C, Hellman U, et al. (2004) Identification of the chicken MARCKS phosphorylation site specific for differentiating neurons as Ser 25 using a monoclonal antibody and mass spectrometry. J Proteome Res 3: 84-90. (Pubitemid 38233454)
25. Toledo A, Zolessi FR, Arruti C (2013) A novel effect of MARCKS phosphorylation by activated PKC: the dephosphorylation of its serine 25 in chick neuroblasts. PLoS One 8: e62863.
26. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129-2141. (Pubitemid 37161770)
27. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, et al. (2005) The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 33: D284-288. (Pubitemid 40207879)
28. Huang da W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
29. Sharma P, Veeranna, Sharma M, Amin ND, Sihag RK, et al. (2002) Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J Biol Chem 277: 528-534.
30. Sun KH, Lee HG, Smith MA, Shah K (2009) Direct and indirect roles of cyclin-dependent kinase 5 as an upstream regulator in the c-Jun NH2-terminal kinase cascade: relevance to neurotoxic insults in Alzheimer's disease. Mol Biol Cell 20: 4611-4619.
31. Blom N, Sicheritz-Ponten T, Gupta R, Gammeltoft S, Brunak S (2004) Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4: 1633-1649. (Pubitemid 38738322)
32. Taniguchi H, Manenti S, Suzuki M, Titani K (1994) Myristoylated alanine-rich C kinase substrate (MARCKS), a major protein kinase C substrate, is an in vivo substrate of proline-directed protein kinase(s). A mass spectroscopic analysis of the post-translational modifications. J Biol Chem 269: 18299-18302.
33. Chi Y, Welcker M, Hizli AA, Posakony JJ, Aebersold R, et al. (2008) Identification of CDK2 substrates in human cell lysates. Genome Biol 9: R149.
34. Pant AC, Veeranna, Pant HC, Amin N (1997) Phosphorylation of human high molecular weight neurofilament protein (hNF-H) by neuronal cyclin-dependent kinase 5 (cdk5). Brain Res 765: 259-266.
35. Su SC, Tsai LH (2011) Cyclin-dependent kinases in brain development and disease. Annu Rev Cell Dev Biol 27: 465-491.
36. Terada M, Yasuda H, Kogawa S, Maeda K, Haneda M, et al. (1998) Expression and activity of cyclin-dependent kinase 5/p35 in adult rat peripheral nervous system. J Neurochem 71: 2600-2606. (Pubitemid 28531273)
37. Stumpo DJ, Bock CB, Tuttle JS, Blackshear PJ (1995) MARCKS deficiency in mice leads to abnormal brain development and perinatal death. Proc Natl Acad Sci U S A 92: 944-948.
38. Gatlin JC, Estrada-Bernal A, Sanford SD, Pfenninger KH (2006) Myristoylated, alanine-rich C-kinase substrate phosphorylation regulates growth cone adhesion and pathfinding. Mol Biol Cell 17: 5115-5130. (Pubitemid 44907355)
39. Calabrese B, Halpain S (2005) Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 48: 77-90. (Pubitemid 41384167)
40. Scarlett CO, Blackshear PJ (2003) Neuroanatomical development in the absence of PKC phosphorylation of the myristoylated alanine-rich C-kinase substrate (MARCKS) protein. Brain Res Dev Brain Res 144: 25-42. (Pubitemid 36897695)
41. Manenti S, Yamauchi E, Sorokine O, Knibiehler M, Van Dorsselaer A, et al. (1999) Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro. Biochem J 340 (Pt 3): 775-782. (Pubitemid 29312877)
42. Toledo A, Arruti C (2009) Actin modulation of a MARCKS phosphorylation site located outside the effector domain. Biochem Biophys Res Commun 383: 353-357.
43. Zolessi FR, Hellman U, Baz A, Arruti C (1999) Characterization of MARCKS (Myristoylated alanine-rich C kinase substrate) identified by a monoclonal antibody generated against chick embryo neural retina. Biochem Biophys Res Commun 257: 480-487. (Pubitemid 29301469)
44. Zolessi FR, Arruti C (2001) Sustained phosphorylation of MARCKS in differentiating neurogenic regions during chick embryo development. Brain Res Dev Brain Res 130: 257-267. (Pubitemid 33000090)
45. Solomonia RO, Apkhazava D, Nozadze M, Jackson AP, McCabe BJ, et al. (2008) Different forms of MARCKS protein are involved in memory formation in the learning process of imprinting. Exp Brain Res 188: 323-330.
46. Hawasli AH, Bibb JA (2007) Alternative roles for Cdk5 in learning and synaptic plasticity. Biotechnol J 2: 941-948. (Pubitemid 47377101)
47. Hawasli AH, Benavides DR, Nguyen C, Kansy JW, Hayashi K, et al. (2007) Cyclin-dependent kinase 5 governs learning and synaptic plasticity via control of NMDAR degradation. Nat Neurosci 10: 880-886. (Pubitemid 47018172)
48. Goswami T, Li X, Smith AM, Luderowski EM, Vincent JJ, et al. (2012) Comparative phosphoproteomic analysis of neonatal and adult murine brain. Proteomics 12: 2185-2189.
49. Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, et al. (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143: 1174-1189.
50. Nordman JC, Kabbani N (2012) An interaction between alpha7 nicotinic receptors and a G-protein pathway complex regulates neurite growth in neural cells. J Cell Sci 125: 5502-5513.
51. Iida N, Kozasa T (2004) Identification and biochemical analysis of GRIN1 and GRIN2. Methods Enzymol 390: 475-483. (Pubitemid 39370669)
52. Chen LT, Gilman AG, Kozasa T (1999) A candidate target for G protein action in brain. J Biol Chem 274: 26931-26938.
53. Connell-Crowley L, Le Gall M, Vo DJ, Giniger E (2000) The cyclin-dependent kinase Cdk5 controls multiple aspects of axon patterning in vivo. Curr Biol 10: 599-602. (Pubitemid 30329446)
54. Hahn CM, Kleinholz H, Koester MP, Grieser S, Thelen K, et al. (2005) Role of cyclin-dependent kinase 5 and its activator P35 in local axon and growth cone stabilization. Neuroscience 134: 449-465. (Pubitemid 41111775)
55. Bernasconi F, Malgaroli A, Vallar L (2006) Independent regulation of Rap1 and mitogen-activated protein kinase by the alpha chain of Go. Neurosignals 15: 180-189. (Pubitemid 46895639)
56. Luttrell DK, Luttrell LM (2003) Signaling in time and space: G protein-coupled receptors and mitogen-activated protein kinases. Assay Drug Dev Technol 1: 327-338.
57. Harada T, Morooka T, Ogawa S, Nishida E (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol 3: 453-459. (Pubitemid 32422080)
58. Utreras E, Futatsugi A, Rudrabhatla P, Keller J, Iadarola MJ, et al. (2009) Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35. J Biol Chem 284: 2275-2284.
59. Utreras E, Keller J, Terse A, Prochazkova M, Iadarola MJ, et al. (2012) Transforming growth factor-beta1 regulates Cdk5 activity in primary sensory neurons. J Biol Chem 287: 16917-16929.
60. Uchida Y, Ohshima T, Sasaki Y, Suzuki H, Yanai S, et al. (2005) Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 10: 165-179. (Pubitemid 40287519)
61. Horiuchi Y, Asada A, Hisanaga S, Toh-e A, Nishizawa M (2006) Identifying novel substrates for mouse Cdk5 kinase using the yeast Saccharomyces cerevisiae. Genes Cells 11: 1393-1404. (Pubitemid 44774202)
62. Tanaka H, Morimura R, Ohshima T (2012) Dpysl2 (CRMP2) and Dpysl3 (CRMP4) phosphorylation by Cdk5 and DYRK2 is required for proper positioning of Rohon-Beard neurons and neural crest cells during neurulation in zebrafish. Dev Biol 370: 223-236.
63. Gonzalez-Billault C, Avila J (2000) Molecular genetic approaches to microtubule-associated protein function. Histol Histopathol 15: 1177-1183.
64. Jimenez-Mateos EM, Paglini G, Gonzalez-Billault C, Caceres A, Avila J (2005) End binding protein-1 (EB1) complements microtubule-associated protein-1B during axonogenesis. J Neurosci Res 80:350-359. (Pubitemid 40780823)
65. Trivedi N, Marsh P, Goold RG, Wood-Kaczmar A, Gordon-Weeks PR (2005) Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons. J Cell Sci 118: 993-1005. (Pubitemid 40484889)
66. Kawauchi T, Chihama K, Nabeshima Y, Hoshino M (2003) The in vivo roles of STEF/Tiam1, Rac1 and JNK in cortical neuronal migration. EMBO J 22: 4190-4201. (Pubitemid 37021747)
67. Pigino G, Paglini G, Ulloa L, Avila J, Caceres A (1997) Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons. J Cell Sci 110 (Pt 2): 257-270. (Pubitemid 27075870)
68. Francis F, Koulakoff A, Boucher D, Chafey P, Schaar B, et al. (1999) Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 23: 247-256. (Pubitemid 29315721)
69. Tanaka T, Serneo FF, Tseng HC, Kulkarni AB, Tsai LH, et al. (2004) Cdk5 phosphorylation of doublecortin ser297 regulates its effect on neuronal migration. Neuron 41: 215-227. (Pubitemid 38125183)
70. Graham ME, Ruma-Haynes P, Capes-Davis AG, Dunn JM, Tan TC, et al. (2004) Multisite phosphorylation of doublecortin by cyclin-dependent kinase 5. Biochem J 381: 471-481. (Pubitemid 38969692)
71. Tseng HC, Ovaa H, Wei NJ, Ploegh H, Tsai LH. (2005) Phosphoproteomic analysis with a solid-phase capture-release-tag approach. Chem Biol 12:769-777. (Pubitemid 41009156)
72. Hernández F, Lucas JJ, Avila J. (2013) GSK3 and tau: two convergence points in Alzheimer's disease. J Alzheimers Dis Suppl 1:S141-4.
73. Lucas JJ, Hernández F, Gómez-Ramos P, Morán MA, Hen R, Avila J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J 20:27-39. (Pubitemid 32099099)
74. Utreras E, Maccioni R, González-Billault C. (2009) Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells. Neuroscience 161:978-987.